✦ LIBER ✦

A multicenter phase II study of the cryptophycin analog LY355703 in patients with platinum-resistant ovarian cancer

✍ Scribed by G D’AGOSTINO; J DEL CAMPO; B MELLADO; M.A. IZQUIERDO; T MINARIK; L CIRRI; L MARINI; J.L. PEREZ-GRACIA; G SCAMBIA

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase 2 study of cryptophycin 52 ( LY355

✍ Edelman, M 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Altretamine (hexamethylmelamine) in the

✍ Nina Keldsen; Hanne Havsteen; Ignace Vergote; Kamma Bertelsen; Anders Jakobsen 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Phase II study of cetrorelix, a luteiniz

✍ Claire F Verschraegen; Silke Westphalen; Wei Hu; Evelyne Loyer; Andrzej Kudelka; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 130 KB

A phase II trial of intraperitoneal inte

✍ Anda M. Vlad; Raluca A. Budiu; Diana E. Lenzner; Yun Wang; Julia A. Thaller; Kel 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 375 KB

Phase II study of bevacizumab with lipos

✍ Verschraegen, C. F.; Czok, S.; Muller, C. Y.; Boyd, L.; Lee, S. J.; Rutledge, T. 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 144 KB

Phase II Study of Gemcitabine and Doceta

✍ Garcia, Agustin A.; Yessaian, Anne; Pham, Huyen; Facio, Grace; Muderspach, Laila 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 177 KB